Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical tria
(Hinzugefügt: 05.02.2021 um 20:05 Uhr)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
(Hinzugefügt: 27.01.2021 um 11:33 Uhr)
Colchicine reduces the risk of COVID-19-related complications Positive results from COLCORONA trial show that colchicine is the only effective oral medication for treating non-hospitalized patients
(Hinzugefügt: 23.01.2021 um 09:09 Uhr)